BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8793787)

  • 1. Prevalence of scoliosis in beta-thalassemia.
    Korovessis PG; Papanastasiou D; Tiniakou M; Beratis NG
    J Spinal Disord; 1996 Apr; 9(2):170-3. PubMed ID: 8793787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of scoliosis in beta-thalassemia and follow-up evaluation.
    Korovessis P; Papanastasiou D; Tiniakou M; Beratis NG
    Spine (Phila Pa 1976); 1996 Aug; 21(15):1798-801. PubMed ID: 8855465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural History of Untreated Scoliosis in beta-Thalassemia.
    Papanastasiou DA; Ellina A; Baikousis A; Pastromas B; Iliopoulos P; Korovessis P
    Spine (Phila Pa 1976); 2002 Jun; 27(11):1186-90. PubMed ID: 12045516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping.
    Khalifa AS; Salem M; Mounir E; El-Tawil MM; El-Sawy M; Abd Al-Aziz MM
    Pediatr Diabetes; 2004 Sep; 5(3):126-32. PubMed ID: 15450007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: a multicenter study.
    Mirmomen S; Alavian SM; Hajarizadeh B; Kafaee J; Yektaparast B; Zahedi MJ; Zand V; Azami AA; Hosseini MM; Faridi AR; Davari K; Hajibeigi B
    Arch Iran Med; 2006 Oct; 9(4):319-23. PubMed ID: 17061602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of thyroid function in two hundred patients with beta-thalassemia major.
    Zervas A; Katopodi A; Protonotariou A; Livadas S; Karagiorga M; Politis C; Tolis G
    Thyroid; 2002 Feb; 12(2):151-4. PubMed ID: 11916284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonographic assessment of the prevalence of cholelithiasis and biliary sludge in beta-thalassemia patients in Iran.
    Lotfi M; Keramati P; Assdsangabi R; Nabavizadeh SA; Karimi M
    Med Sci Monit; 2009 Aug; 15(8):CR398-402. PubMed ID: 19644415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of HBV and HCV among the multi-transfused beta thalassemic major patients in a day care centre of blood transfusion department of Mymensingh Medical College Hospital.
    Chakrabarty P; Rudra S; Hossain MA
    Mymensingh Med J; 2014 Apr; 23(2):235-41. PubMed ID: 24858148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of thyroid functions and its role in body growth in thalassemia major.
    Jain M; Sinha RS; Chellani H; Anand NK
    Indian Pediatr; 1995 Feb; 32(2):213-9. PubMed ID: 8635784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
    Moayeri H; Oloomi Z
    Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osteoporosis and the thalassemia "trait"].
    Orzincolo C; Castaldi G; Scutellari PN; Vita F; Bagni B
    Radiol Med; 1993; 85(1-2):23-7. PubMed ID: 8480045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological, immunological and histological aspects in adult beta-thalassemic patients with chronic hepatitis C virus infection.
    Siagris D; Giannakoulas N; Christofidou M; Tsamandas A; Lekkou A; Thomopoulos K; Zoumbos N; Labropoulou-Karatza Ch
    Liver Int; 2004 Jun; 24(3):204-9. PubMed ID: 15189270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unbalanced bone turnover in children with beta-thalassemia.
    Salama OS; Al-Tonbary YA; Shahin RA; Eldeen OA
    Hematology; 2006 Jun; 11(3):197-202. PubMed ID: 17325962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coenzyme Q10 levels in β-thalassemia and its association with ferritin levels and chelation therapy.
    Karakukcu C; Karakukcu M; Unal E; Patiroglu T; Ozdemir MA; Torun YA; Tang PH
    Hemoglobin; 2012; 36(3):219-29. PubMed ID: 22483337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrinopathies in Turkish children with Beta thalassemia major: results from a single center study.
    Isik P; Yarali N; Tavil B; Demirel F; Karacam GB; Sac RU; Fettah A; Ozkasap S; Kara A; Tunc B
    Pediatr Hematol Oncol; 2014 Oct; 31(7):607-15. PubMed ID: 24854890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricuspid regurgitation in patients with beta-thalassemia major.
    Wu KH; Chang JS; Su BH; Peng CT
    Ann Hematol; 2004 Dec; 83(12):779-83. PubMed ID: 15449031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of combined therapy with deferoxamine and deferiprone on serum ferritin level of beta-thalassemic patients.
    Mirbehbahani N; Jahazi A; Rahim Abad HH
    Hematology; 2012 May; 17(3):183-6. PubMed ID: 22664119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age related IGF-I changes and IGF-I generation in thalassemia major.
    Soliman AT; Abushahin A; Abohezeima K; Khalafallah H; Adel A; Elawwa A; Elmulla N
    Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():278-83. PubMed ID: 21705978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in pattern of erythropoietin response between beta-thalassemia/hemoglobin E children and adults.
    Sukpanichnant S; Opartkiattikul N; Fucharoen S; Tanphaichitr VS; Hasuike T; Tatsumi N
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():134-7. PubMed ID: 9640615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.
    Mokhtar GM; Adly AA; El Alfy MS; Tawfik LM; Khairy AT
    Hemoglobin; 2010; 34(1):78-94. PubMed ID: 20113292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.